Article: Phytomedics Inc. Receives Second Round of Equity Investment From Poalim Investments Ltd.

DAYTON, N.J., Sept 7 /PRNewswire/ --

Phytomedics Inc. is very pleased to announce that it has just received a second round of equity investment from Poalim Investments Ltd., one of Israel's largest financial enterprises and a leader among the investment industry.

Poalim Investments Ltd. is also a limited partner in the BioTech M.A.H. Plant Genomic Fund, jointly run by Makhteshim-Agan Industries Ltd., a leading agricultural chemical company, and Hazera Quality Seeds Ltd., Israel's leading seed company, who previously announced a strategic relationship with Phytomedics in January.

"We are very pleased about the continued equity investment into ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!